⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ETON News
Eton Pharmaceutcials, Inc. Common Stock
Form 8-K
sec.gov
ETON
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
globenewswire.com
ETON
Form 8-K
sec.gov
ETON
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
globenewswire.com
ETON
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
ETON
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
globenewswire.com
ETON
Form 8-K
sec.gov
ETON
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
globenewswire.com
ETON
Form 8-K
sec.gov
ETON
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
globenewswire.com
ETON